Clinical Trial: Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Kidney Cancer
Study Type: INTERVENTIONAL
Official Title: A Pilot Study of the Immunomodulatory Agent Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
Brief Summary:
The purpose of this study is to determine the safety and tolerability of acarbose in combination of immunotherapy based standard of care therapy in advanced renal cell carcinoma patients.
Read more